Introduction: Data audits within clinical settings are extensively used as a major strategy to identify errors, monitor study operations and ensure high-quality data. However, clinical trial guidelines are non-specific in regards to recommended frequency, timing and nature of data audits. The absence of a well-defined data quality definition and method to measure error undermines the reliability of data quality assessment. This review aimed to assess the variability of source data verification (SDV) auditing methods to monitor data quality in a clinical research setting.
Introduction 67
Clinical trials are vital to enabling a greater understanding of how interventions work 68 in humans [1] . Therefore, it is essential that clinical trials produce accurate, complete 69 and relevant data [2, 3] . The integral nature of good quality data and documentation 70 practice is well accepted within the research community as conclusions and 71 recommendations rely heavily on the outcomes of the data. As part of quality 72 assurance practices, modifications to study practices are made to prevent errors 73 occurring, however, no universally accepted method for measuring error rates 74 currently exists [4] . Within the published literature, it is generally accepted that if 75 greater than 10% of data is missing or incorrect, analysis of the data is considered to 76 be unreliable [5, 6] . Data audits are conducted to verify that data is appropriately 77 documented, coded and classified and may assess compliance to a protocol. To 78 allow for this all data must be recorded on source documentation to reconstruct the 79 trial as it happened and allow for an independent observer to confirm the data 80 validity [7] . Without source data, audits cannot be completed and the fundamental 81 principle of protecting participant rights, safety and well-being cannot be guaranteed. 82
Therefore, data audits work closely with quality assurance processes by allowing on-83 site monitoring activities to aid study investigators to improve data quality and overall 84 study operations. Quality assurance audits, within clinical settings, are extensively 85 used and are a significant strategy to ensure high-quality data [4, 5, 8, 9] . However, 86 on-site audits are infrequently published or reported. This may be due to non-specific 87 audit methods, lack of time and funding or the publishing of audit methodology is not 88 seen as a 'value added' activity [10] [11] [12] . Published methodology papers are 89 warranted to promote routine auditing within academic and commercial clinical 90 research settings. 91
92
In clinical trials auditors should evaluate whether the data is collected and managed 93 in accordance with a known quality standard such as the International Conference 94 on Harmonisation (ICH) guideline E6 on Good Clinical Practice (GCP), 1996 [13] . 95
According to the ICH-GCP, there is a need for on-site monitoring before, during and 96 after a clinical trial, but they do not specify the frequency and nature of such 97 monitoring. This refers to the complete clinical record of the participant and includes 98 the process of applying eligibility criteria and participant consent throughout the trial 99 Thus, the aim of this review is to assess the variability of SDV auditing methods to 135 monitor data quality in a clinical research setting. It was hypothesised that data 136 quality variations are due to unclear SDV auditing methods existing within clinical 137 research settings. 138 139 140
Material and methods 141
A literature review was conducted with reference to frameworks for establishing 142 evidence for practice provided by the Australian Government National Health and 143
Medical Research Council (NHMRC) [23] and followed the requirements of the 144
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 145 checklist [24] . To ensure a standard and detailed method was applied the Cochrane 146
Handbook for Systematic Reviews of Interventions was consulted for guidance [25] . 147
Studies reviewed were assessed for quality to identify potential risk of bias using the 148
Academy of Nutrition and Dietetics Evidence Analysis Library quality rating checklist 149
[26]. The review addressed the research question, "Is there consistency in SDV 150 auditing methods to monitor da ta quality in clinical research?" 151
152
A methodical search was conducted using MEDLINE, Scopus and Science Direct 153 scientific databases to identify relevant articles that had assessed data quality 154 through the use of a SDV audit. An identical search strategy was applied using the 155 
Results 173
A total of 802 articles were identified with 183 articles not meeting the inclusion 174 criteria (49=non-English and 134=non-human participants). Please refer to Figure 1  175 for full details. 176 177
Description of studies 178
Ultimately, 15 relevant published articles were scrutinised and summarised in Table  179 1. Eight articles assessed the accuracy, completeness, and reliability of a database 180 [14, 15, [27] [28] [29] [30] [31] [32] and seven assessed the performance and value of a SDV method [5, 181 6, 9, 12, 33-35] . There was substantial heterogeneity in study design, in particular 182 with respect to error coding, classification, and calculation. Three articles reported 183 data from randomised controlled trials (RCTs) [27, 28, 33] ; three from comparative 184 cohort studies [9, 15, 29] ; two from interrupted time series with no control [12, 14] ; 185 two from historical control studies [5, 6] ; three from cohort studies with no 186 comparison [30, 31, 34] ; one from a single-arm study [35] and one from a pre-187 test/post-test study design [32] . All 15 articles were deemed to have sound study 188 design and scientific rigour overall (Additional file 1). 189
191
The types of clinical studies from the 15 included articles are summarised in 
Methods of source data verification 199
The nature and extent of the SDV audit methods varied depending upon the amount 200 of data collected and the complexity of the source document [5] . Data 201 inconsistencies resulted from how studies recorded information and how they 202 entered, stored and formatted the data [29] . Two articles demonstrated that health 203 records and auditing tools differed within the same study [9, 29] . Good data quality 204 also appeared to be related to the effectiveness of data-monitoring plans which had 205 a functioning structure and efficiently organised data [34] . In turn, knowledge, and 206 experience of data entry personnel involved in data management were related to the 207 error rate [34] . Abstraction and transcription of data were identified as the steps most 208 likely to introduce error [5, 34] . Similarly, the design of the CRF was considered 209 important to minimise error and needs to be emphasised [34] . 210
211
Three publications which implemented multiple SDV audits on the same dataset 212
found an improvement in data quality over the duration of the study [12, 15, 29] . 213
Completion of a re-audit reported a 50% decrease in the overall error rate. The 214 remaining errors existed due to data existing on the source document but not 215 entered into the database, rather than minor and major incorrect values [29] . 216 Mphatswe et al. [12] found the level of completeness increased 38% and accuracy 217 increased 28% when comparing the first and third audits. A re-audit of data elements 218 was identified as suboptimal and should only be targeted for further continuous data 219 quality interventions [15, 32] . 220 221 SDV was considered to be time-consuming, expensive and not necessarily free from 222 error [9, 28, 33, 35] , however, interpretation of on-site issues provided much more 223 than just identification of error [6] . For example, identifying whether errors were 224 systematic allowed for potential solutions and recommendations to be introduced for 225 overall quality improvement [5, 6] . Two publications suggested that central 226 monitoring, such as remote SDV and risk assessment are more effective at 227 identifying data errors when compared to traditional on-site 100% SDV, the method 228 recommended by the ICH-GCP [9, 33] . For a precise understanding of how and 229
where errors lie within a dataset, on-site monitoring can provide greater insight into 230 problems and aid in identifying potential solutions for improvement, not only within 231 the data, but the clinical study itself [6] . 232 233
Variables, frequency, and amount of source data verification 234
Only one included publication completed traditional on-site 100% SDV [34] . All 235 others completed a random sample of data points, CRFs, study participants or 236 centres. Key data variables were not defined consistently but included important data 237 items such as primary and secondary endpoints, informed consent, eligibility criteria, 238 randomisation distribution, adverse events and safety data [5, 9, 12, 14, 27, 28, 33] . 239
Further to this, seven publications did not state or specify if variables were critical to 240 the outcome of the study [6, 15, [29] [30] [31] [32] 35] . 241
242
The frequency of SDV audits was stated in nine publications, in which two conducted 243 SDV before, during and after data entry [12, 28] , though one did not report on 244 specific time intervals [12] . Time points varied (6-24 months) between publications 245 [9, 15, 28, 31, 35] and this was due to study design and/or implementation of study 246 interventions such as an electronic medical record (EMR) [14] . Two publications 247 depended on completing a second audit based on the percentage of expected 248 participant enrollments (20-30% and 70-80%) [5] as well as identifying sites that 249 required major quality interventions [29] . However, no description was given in 250 regards to what determined poor quality data. 251
252
The number of participants, files and centres included for each SDV audit varied and 253 the amount of SDV varied depending on the nature and size of the data generated. 254
Random sampling was the most common auditing method implemented, however 255 the amount of participants (8-94%) [9, 14, 15, [27] [28] [29] [30] 33] , files (3-10%) [31, 35] or 256 centres (11-35%) [6, 12, 32] randomly selected differed substantially. The remaining 257 two publications implemented methods including; a specific number of files per 258 centre, [34] and expected participant enrolment [5] . 259 260
Error coding, classification, and calculation 261
The method used to code, classify and calculate error varied widely. Of the 14 262 publications that classified or coded data only eight provided clear definitions for the 263 codes [5, 9, 12, 27, 29, 31, 34, 35] . One did not specify coding or an explanation of 264 how error rates were calculated at all [28] . Published auditing methods were 265 implemented in four publications, the National Cancer Institute (NCI) method for 266 auditing cases [5, 27] 
and the European Organisation for the Research and 267
Treatment of Cancer (EORTC) [29, 34] . The total error was described in the 268 literature by dividing total erroneous and missing points by total audited points [5, 14, 269 29], a standard error calculation [30, 31] , and calculating an agreement rate [6, 12] . 270
Thus, dissimilarities in the available auditing methods were a key finding 271 demonstrating the heterogeneity in SDV auditing methods. 272
Identifying errors through retrospective checking and data cleaning was a more 273 successful method when compared to detection through data entry itself [28] . 274
Reporting of error rates depended on how data was abstracted within the individual 275 studies and results varied greatly (<1% to 71%). No systematic pattern was 276 determined for CRF-to-database audits. Reported discrepancies had a minor impact 277 on the primary outcome of the study, with the error reported at <1% [5, 33] . On the 278 other hand, both source document-to-database and source document-to-CRF 279 average error rates were much greater (~10-20%) for the majority of publications 280 (n=9). The main source of error (0.4-14.5%) was from transcribing data from paper to 281 electronic records [34] . Knowledge and experience of the data management and 282 entry personnel were directly related to efficient data collection and organisation, 283 which was linked to the percentage of error found [34] . 284
285
Visual inspection, by manually checking data through SDV, allows identification of 286 errors that fall outside predetermined values [28, 32] . The majority of publications 287 implemented continuous extensive range, logic, and consistency checks via an 288 electronic database [5, 6, 28, 30, 32, 33] . Errors within these articles were 289 considerably lower when compared to those that did not implement additional 290 checks. Errors were identified instantly and correctly resubmitted prior to auditing 291 
Discussion 295
This literature review has identified that there are limited methodological publications 296 available on quality assurance procedures within clinical research settings. With the 297 available published data, this review highlights the heterogeneity of SDV auditing 298 practices and the significant variations in procedures, policies, requirements, and 299 technologies of the audit designs used in clinical studies. As only four publications 300 used an established SDV audit method considerable variation amongst terminology 301 and methodology was found [5, 27, 29, 34] Additionally, key data for auditing was defined inconsistently throughout studies and 311 variations may have been subject to the study investigators personal judgement. 312
However, completing 100% SDV on secondary data that is not subsequently used 313 for analyses may not be cost-effective. This aligns with Eisenstein et al. [19] who 314 compared the amount of data collected and the effect this had on the cost of the 315 clinical trial. They found that the most efficient way to reduce trial costs, without 316 compromising scientific objectives, was to reduce the number of on-site monitoring 317 visits. Despite this, the Institute of Medicine is concerned that any discrepant data 318 points identified during monitoring will bring into question the reliability and validity of 319 the whole dataset [36] . From the outcomes of this review the authors suggest that 320 data audit characteristics such as conducting 100% SDV on critical endpoints and 321 random selection of 10% SDV of non-critical endpoints, could be a more accurate 322 and cost-effective method to ensure data quality. A quality improvement plan should 323 be implemented for a follow-up audit if the error is found to be greater than 10%, to 324 revise and improve site procedures. This suggested data audit method would need 325 to be tested against a traditional method (e.g. 100% SDV) to provide evidence for 326
implementation. 327 328
Although there is currently a lack of knowledge regarding alternative auditing 329 methods, the literature supports changing the focus from on-site SDV audits to 330 employing other methods to monitor clinical trials [33] outcomes. The majority of the literature included for the review was considered to 382 have low levels of evidence according to study types [23] . Additionally, the focus on 383 clinical research trials may of ruled out relevant articles from the informatics and 384 library science literature. Limited articles took into consideration whether a SDV audit 385 was effective in achieving quality assurance. These limitations made it difficult to 386 determine and justify clinical significance in relation to acceptable data quality. The 387 lack of evidence in the literature regarding methods of SDV is a strong indication of 388 the need to conduct further research in this area. The lack of adequate detail in the 389 original publications may also have affected the strength of our conclusions. All 390 articles differed in their study size, country of origin, ethnicity, education level, 391 resources and method for implementing a SDV were varied. Therefore, the main 392 limitation of this review is being unable to compare the methods of SDV auditing 393 against each other. As this area of research is growing, it was the researchers' 394 decision to not use only MeSH terms, descriptors and concepts. Consideration is 395 required as the review spans a number of disciplines and limiting to MeSH terms 396 may in turn limits the search strategy and number of relevant articles returned. 397
Although MeSH terms were not incorporated in the search strategy, a stringent 398 systematic procedure was followed and guided by the NHMRC framework and 399 PRISMA checklist. Further, a quality-rating process was implemented to identify 400 potential bias and a range of scientific databases were utilised as recommended by 401 the Cochrane handbook highlighting the strength of this review. recommendations for using a combination of a random sample of participants' 427 records (≥10%); both critical and non-critical variables and multiple audits (before, 428 during and after) with quality improvement feedback should be included in the SDV 429 audits. This combination is considered to be a cost-effective solution to ensure data 430 quality, at least until further studies are conducted. 
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